Table 1.
Demographic and medical characteristics by PHQ-9 category score
| Characteristic | PHQ-9 category score |
All women | Pa | ||
|---|---|---|---|---|---|
| <5 | 5-9 | 10+ | |||
| Total No. | 53 (22.9) | 106 (45.9) | 72 (31.2) | 231 (100) | |
| Demographics | |||||
| Site, No. (%) | |||||
| Dana Farber | 16 (30.2) | 49 (46.2) | 23 (31.9) | 88 (38.1) | .23 |
| Johns Hopkins | 13 (24.5) | 20 (18.9) | 16 (22.2) | 49 (21.2) | |
| UCLA | 24 (45.3) | 37 (34.9) | 33 (45.8) | 94 (40.7) | |
| Current age, mean (SD) [range], y | 47.4 (4.6) [34.9-55.4] | 44.4 (6.6) [23.2-54.5] | 44.8 (7.1) [26.5-54.2] | 45.2 (6.4) [23.2-55.4] | .02 |
| Age at diagnosis, mean (SD), y | 44.7 (4.2) | 42.0 (6.2) | 42.1 (7.0) | 42.6 (6.2) | .02 |
| Years from diagnosis, mean (SD) | 2.7 (1.2) | 2.5 (1.1) | 2.7 (1.1) | 2.6 (1.1) | .40 |
| Race, No. (%) | |||||
| White (includes Hispanic) | 44 (83.0) | 83 (79.1) | 59 (83.1) | 186 (81.2) | .74b |
| Black, non-Hispanic | 6 (11.3) | 8 (7.6) | 5 (7.0) | 19 (8.3) | |
| Asian | 2 (3.8) | 10 (9.5) | 7 (9.9) | 19 (8.3) | |
| Other | 1 (1.9) | 4 (3.8) | 0 (0.0) | 5 (2.2) | |
| Hispanic, No. (%) | 7 (13.2) | 12 (11.3) | 4 (5.6) | 23 (10.0) | .30 |
| Marital status, No. (%) | |||||
| Married or living as married | 35 (66.0) | 71 (67.0) | 42 (58.3) | 148 (64.1) | .47c |
| Divorced | 4 (7.6) | 18 (17.0) | 14 (19.4) | 36 (15.6) | |
| Widowed | 0 (0.0) | 1 (0.9) | 1 (1.4) | 2 (0.9) | |
| Single | 14 (26.4) | 16 (15.1) | 15 (20.8) | 45 (19.5) | |
| Education, No. (%) | |||||
| No college degree | 11 (20.8) | 21 (19.8) | 11 (15.3) | 43 (18.6) | .88 |
| College degree | 24 (45.3) | 45 (42.5) | 31 (43.1) | 100 (43.3) | |
| Postgraduate degree | 18 (34.0) | 40 (37.7) | 30 (41.7) | 88 (38.1) | |
| Employment status, No. (%) | |||||
| Employed full-time | 34 (64.2) | 76 (71.7) | 46 (63.9) | 156 (67.5) | .52 |
| Employed part-time | 9 (17.0) | 11 (10.4) | 14 (19.4) | 34 (14.7) | |
| Not employed | 10 (18.9) | 19 (17.9) | 12 (16.7) | 41 (17.8) | |
| Annual household income (missing = 17), No. (%) | |||||
| <$60 K | 11 (22.5) | 17 (17.4) | 17 (25.4) | 45 (21.0) | .46 |
| $60K-$100K | 10 (20.4) | 20 (20.4) | 18 (26.9) | 48 (22.4) | |
| >$100 K | 28 (57.1) | 61 (62.2) | 32 (47.8) | 121 (56.5) | |
| Medical characteristics | |||||
| BMI, mean (SD), kg/m2 | 27.4 (6.7) | 26.1 (5.6) | 27.8 (6.2) | 26.9 (6.0) | .16 |
| Surgery, No. (%) | |||||
| Lumpectomy | 18 (34.0) | 41 (38.7) | 33 (45.3) | 92 (39.8) | .24 |
| Mastectomy | 35 (66.0) | 59 (55.7) | 36 (50.0) | 130 (56.3) | |
| No surgery | 0 (0.0) | 6 (5.7) | 3 (4.2) | 9 (3.9) | |
| Had chemotherapy, No. (%) | 30 (56.6) | 70 (66.0) | 43 (59.7) | 143 (61.9) | .46 |
| Had radiation, No. (%) | 31 (58.5) | 70 (66.0) | 50 (69.4) | 151 (65.4) | .44 |
| Took trastuzumab (missing = 5), No. (%) | 9 (17.0) | 32 (30.8) | 17 (24.6) | 58 (25.7) | .17 |
| Endocrine therapy, No. (%) | |||||
| Current | 32 (60.4) | 68 (64.2) | 51 (70.8) | 151 (64) | .45 |
| Past (missing = 6) | 6 (11.5) | 17 (16.5) | 12 (17.1) | 35 (15.6) | .66 |
| Ovarian suppression, Current, No. (%) | 8 (15.1) | 17 (16.0) | 9 (12.5) | 34 (14.7) | .80 |
| Menopausal status at diagnosis, No. (%) | |||||
| Premenopausal | 34 (64.2) | 78 (74.3) | 57 (80.3) | 169 (73.8) | .13d |
| Perimenopausal | 7 (13.2) | 7 (6.7) | 9 (12.7) | 23 (10.0) | |
| Postmenopausal | 4 (7.6) | 1 (1.0) | 1 (1.4) | 6 (2.6) | |
| Unknown | 8 (15.1) | 19 (18.1) | 4 (5.6) | 31 (13.5) | |
a
Two-sided P values less than .05 were considered statistically significant; analyses used analysis of variance for continuous variables and χ2 tests for categorical variables. BMI = body mass index; PHQ-2 = Patient Health Questionnaire 2 item; PHQ-9 = Patient Health Questionnaire 9 item; UCLA = University of California Los Angeles.
b
White vs non-White.
c
Married vs unmarried.
d
Premenopausal vs other.